摘要 |
2-oxa-bicyclo[2.2.1]heptane derivatives according to formula (I) and their enantiomers, where for example A represents -(CH2)n-, (E)-CH=CH- or (Z)-CH=CH-, -C=C, -O- or -S-; B represents hydrogen, C1-C10 alkyl, -OR<2>, halogen, C=N, -N3, -COOR<3>; R<1> represents oxygen or a -CH2 group; R<4> represents (a), (b), -COOR<5>, Z represents -(CH2)p-, (E)-CH=CH-, -C=C-; W represents a direct bond, a free or functionally altered hydroxymethylene group or a free or functionally altered group (c), where the OH-group can be in the alpha or beta position; D represents a direct bond, a saturated alkylene group with 1 to 5 C atoms, a branched saturated or a linear or branched unsaturated alkylene group with 2 to 5 C atoms; E represents a direct bond, -C=C- or -CH=CR<7>-; R<8> represents hydrogen, C1-C10 alkyl, C3-C10-cycloalkyl, optionally substituted C6-C12-aryl or a 5 or 6 member heterocyclic residue; and if R<5> represents hydrogen, their salts with physiologically suitable bases, as well as the alpha -, beta - or gamma -cyclodextrinclathrates, as well as compounds of formula (I) encapsulated with liposomes; process for producng them and drugs containing said compounds. |
申请人 |
SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN |
发明人 |
KLAR, ULRICH;VORBRUEGGEN, HELMUT;REHWINKEL, HARTMUT;THIERAUCH, KARL-HEINZ;STUERZEBECHER, CLAUS-STEFFEN |